The FSHD Global Research Foundation has placed a high priority on applications for funding of Translational Research. The Foundation has set aside funding and is calling for proposals by March 2010 that fit into the key identified priority areas of interest for Translational Research for a funding decision in October 2010.
Further to this, the Foundation has budgeted to provide matched funding for a Phase 1 Clinical Trial of a candidate FSHD therapeutic of up to an amount of US$400,000. Proposals are called for by March 2011 for a funding decision in October 2011.